Tidalgo, Lilia .
HRN: 25-88-67 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/17/2024
CEFUROXIME 1.5GM (VIAL)
09/18/2024
09/18/2024
IVT
1.5 Gm
On Cal Prior To OR
Elective Enucleation & Curettage
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes